ExoU Induces Lung Endothelial Cell Damage and Activates Pro-Inflammatory Caspase-1 during Pseudomonas aeruginosa Infection
The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
The Gram-negative, opportunistic pathogen Pseudomonas aeruginosa utilizes a type III secretion system to inject exoenzyme effectors into a target host cell. Of the four best-studied exoenzymes, ExoU causes rapid cell damage and death. ExoU is a phospholipase A2 (PLA2) that hydrolyses host cell membranes, and P. aeruginosa strains expressing ExoU are associated with poor outcomes in critically ill patients with pneumonia. While the effects of ExoU on lung epithelial and immune cells are well studied, a role for ExoU in disrupting lung endothelial cell function has only recently emerged. Lung endothelial cells maintain a barrier to fluid and protein flux into tissue and airspaces and regulate inflammation. Herein, we describe a pulmonary microvascular endothelial cell (PMVEC) culture infection model to examine the effects of ExoU. Using characterized P. aeruginosa strains and primary clinical isolates, we show that strains expressing ExoU disrupt PMVEC barrier function by causing substantial PMVEC damage and lysis, in a PLA2-dependent manner. In addition, we show that strains expressing ExoU activate the pro-inflammatory caspase-1, in a PLA2-dependent manner. Considering the important roles for mitochondria and oxidative stress in regulating inflammatory responses, we next examined the effects of ExoU on reactive oxygen species production. Infection of PMVECs with P. aeruginosa strains expressing ExoU triggered a robust oxidative stress compared to strains expressing other exoenzyme effectors. We also provide evidence that, intriguingly, ExoU PLA2 activity was detectable in mitochondria and mitochondria-associated membrane fractions isolated from P. aeruginosa-infected PMVECs. Interestingly, ExoU-mediated activation of caspase-1 was partially inhibited by reactive oxygen species scavengers. Together, these data suggest ExoU exerts pleiotropic effects on PMVEC function during P. aeruginosa infection that may inhibit endothelial barrier and inflammatory functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ExoU is the most acutely cytotoxic among the four effector proteins because it can induce rapid cell death and is considered to be the main driver of the cytotoxic phenotype.118”
From Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics (2022) · cites this paper as [118]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death
Shi, J., Zhao, Y., Wang, K., Shi, X., Wang, Y., Huang, H., Zhuang, Y., Cai, T., Wang, F., & Shao, F. (2015) · Nature · doi:10.1038/nature15514 · Cited by 6,659
Martinon, F., Burns, K., & Tschopp, J. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00599-3 · Cited by 6,066
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Boucher, H. W., Talbot, G. H., Bradley, J. S., Edwards, J. E., Gilbert, D., Rice, L. B., Scheld, M., Spellberg, B., & Bartlett, J. (2009) · Clinical Infectious Diseases · doi:10.1086/595011 · Cited by 4,958
Normality Tests for Statistical Analysis: A Guide for Non-Statisticians
Ghasemi, A., & Zahediasl, S. (2012) · International Journal of Endocrinology and Metabolism · doi:10.5812/ijem.3505 · Cited by 4,368
Thioredoxin-interacting protein links oxidative stress to inflammasome activation
Zhou, R., Tardivel, A., Thorens, B., Choi, I., & Tschopp, J. (2010) · Nature Immunology · doi:10.1038/ni.1831 · Cited by 2,708 · cited 1×
“Reactive oxygen species are a known danger signal for caspase-1 activation [54,61,62].”
BackgroundA novel heterodimeric cysteine protease is required for interleukin-1βprocessing in monocytes
Thornberry, N. A., Bull, H. G., Calaycay, J. R., Chapman, K. T., Howard, A. D., Kostura, M. J., Miller, D. K., Molineaux, S. M., Weidner, J. R., Aunins, J., et al. (1992) · Nature · doi:10.1038/356768a0 · Cited by 2,572
Gasdermin D is an executor of pyroptosis and required for interleukin-1β secretion
He, W.-T., Wan, H., Hu, L., Chen, P., Wang, X., Huang, Z., Yang, Z.-H., Zhong, C.-Q., & Han, J. (2015) · Cell Research · doi:10.1038/cr.2015.139 · Cited by 2,517
Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE
Rice, L. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/533452 · Cited by 2,310
Inflammasomes in health and disease
Strowig, T., Henao-Mejia, J., Elinav, E., & Flavell, R. (2012) · Nature · doi:10.1038/nature10759 · Cited by 2,230
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
Klionsky, D. J., Abeliovich, H., Agostinis, P., Agrawal, D. K., Aliev, G., Askew, D. S., Baba, M., Baehrecke, E. H., Bahr, B. A., Ballabio, A., et al. (2008) · Autophagy · doi:10.4161/auto.5338 · Cited by 2,230
Clinical relevance of the ESKAPE pathogens
Pendleton, J. N., Gorman, S. P., & Gilmore, B. F. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.13.12 · Cited by 1,423
VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease
Kim, J., Gupta, R., Blanco, L. P., Yang, S., Shteinfer-Kuzmine, A., Wang, K., Zhu, J., Yoon, H. E., Wang, X., Kerkhofs, M., et al. (2019) · Science · doi:10.1126/science.aav4011 · Cited by 793 · cited 3×
“To confirm Mito-MAM enrichment in our model, we verified that extracts contained Prohibitin [56,57] and VDAC-1 [58], two known mitochondria-associated control proteins (Figure 3C).”
BackgroundResultExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury
Finck‐Barbançon, V., Goranson, J., Zhu, L., Sawa, T., Wiener‐Kronish, J. P., Fleiszig, S. M. J., Wu, C., Mende‐Mueller, L., & Frank, D. W. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.4891851.x · Cited by 518
Immune recognition of Pseudomonas aeruginosa mediated by the IPAF/NLRC4 inflammasome
Sutterwala, F. S., Mijares, L. A., Li, L., Ogura, Y., Kazmierczak, B. I., & Flavell, R. A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071239 · Cited by 513
ExoY, an adenylate cyclase secreted by the Pseudomonas aeruginosa type III system
Yahr, T. L., Vallis, A. J., Hancock, M. K., Barbieri, J. T., & Frank, D. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13899 · Cited by 464
Roy‐Burman, A., Savel, R. H., Racine, S., Swanson, B. L., Revadigar, N. S., Fujimoto, J., Sawa, T., Frank, D. W., & Wiener‐Kronish, J. P. (2001) · The Journal of Infectious Diseases · doi:10.1086/320737 · Cited by 455
Feltman, H., Schulert, G., Khan, S., Jain, M., Peterson, L., & Hauser, A. R. (2001) · Microbiology · doi:10.1099/00221287-147-10-2659 · Cited by 446
Merkwirth, C., & Langer, T. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.05.013 · Cited by 403
Hauser, A. R., Cobb, E., Bodí, M., Mariscal, D., Vallés, J., Engel, J. N., & Rello, J. (2002) · Critical Care Medicine · doi:10.1097/00003246-200203000-00005 · Cited by 399
The mechanism of action of the Pseudomonas aeruginosa-encoded type III cytotoxin, ExoU
Sato, H. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg290 · Cited by 390
The exoenzyme S regulon of Pseudomonas aeruginosa
Frank, D. W. (1997) · Molecular Microbiology · doi:10.1046/j.1365-2958.1997.6251991.x · Cited by 370
Sawa, T., Yahr, T. L., Ohara, M., Kurahashi, K., Gropper, M. A., Wiener-Kronish, J. P., & Frank, D. W. (1999) · Nature Medicine · doi:10.1038/7391 · Cited by 362
Relative Contributions of Pseudomonas aeruginosa ExoU, ExoS, and ExoT to Virulence in the Lung
Shaver, C. M., & Hauser, A. R. (2004) · Infection and Immunity · doi:10.1128/iai.72.12.6969-6977.2004 · Cited by 350
Pathogenesis of septic shock in Pseudomonas aeruginosa pneumonia
Kurahashi, K., Kajikawa, O., Sawa, T., Ohara, M., Gropper, M. A., Frank, D. W., Martin, T. R., & Wiener-Kronish, J. P. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7124 · Cited by 316 · cited 2×
“aeruginosa strains expressing ExoU results in bacterial colonization of the lungs, increased propensity for dissemination, and lower dose-dependent morbidity and mortality [3,21,25,29,30].”
BackgroundExoU is a potent intracellular phospholipase
Sato, H., & Frank, D. W. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04194.x · Cited by 287
Fu, H., Coburn, J., & Collier, R. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2320 · Cited by 267
Pseudomonas aeruginosa ExoS and ExoT
Barbieri, J. T., & Sun, J. (2004) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-004-0031-7 · Cited by 254
Cutting Edge: Mitochondrial Assembly of the NLRP3 Inflammasome Complex Is Initiated at Priming
Elliott, E. I., Miller, A. N., Banoth, B., Iyer, S. S., Stotland, A., Weiss, J. P., Gottlieb, R. A., Sutterwala, F. S., & Cassel, S. L. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701723 · Cited by 195
Allewelt, M., Coleman, F. T., Grout, M., Priebe, G. P., & Pier, G. B. (2000) · Infection and Immunity · doi:10.1128/iai.68.7.3998-4004.2000 · Cited by 190
Pendyala, S., Gorshkova, I. A., Usatyuk, P. V., He, D., Pennathur, A., Lambeth, J. D., Thannickal, V. J., & Natarajan, V. (2009) · Antioxidants & Redox Signaling · doi:10.1089/ars.2008.2203 · Cited by 181
Hauser, A. R., & Engel, J. N. (1999) · Infection and Immunity · doi:10.1128/iai.67.10.5530-5537.1999 · Cited by 167
Inflammasomes: Threat-Assessment Organelles of the Innate Immune System
Evavold, C. L., & Kagan, J. C. (2019) · Immunity · doi:10.1016/j.immuni.2019.08.005 · Cited by 166
Jabir, M. S., Hopkins, L., Ritchie, N. D., Ullah, I., Bayes, H. K., Li, D., Tourlomousis, P., Lupton, A., Puleston, D., Simon, A. K., et al. (2015) · Autophagy · doi:10.4161/15548627.2014.981915 · Cited by 163
Biological Effects of Pseudomonas aeruginosa Type III-Secreted Proteins on CHO Cells
Vallis, A. J., Finck‐Barbançon, V., Yahr, T. L., & Frank, D. W. (1999) · Infection and Immunity · doi:10.1128/.67.4.2040-2044.1999 · Cited by 135
Clinical outcomes of type III Pseudomonas aeruginosa bacteremia*
El-Solh, A. A., Hattemer, A., Hauser, A. R., Alhajhusain, A., & Vora, H. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e3182377906 · Cited by 120
Pseudomonas aeruginosa Induces Localized Immunosuppression during Pneumonia
Diaz, M. H., Shaver, C. M., King, J. D., Musunuri, S., Kazzaz, J. A., & Hauser, A. R. (2008) · Infection and Immunity · doi:10.1128/iai.00012-08 · Cited by 115
Pseudomonas aeruginosa Cytotoxin ExoU Is Injected into Phagocytic Cells during Acute Pneumonia
Diaz, M. H., & Hauser, A. R. (2010) · Infection and Immunity · doi:10.1128/iai.01134-09 · Cited by 104
Eicosanoid-mediated proinflammatory activity of Pseudomonas aeruginosa ExoU
Saliba, A. M., Nascimento, D. O., da Silva, M. C. A., de Assis, M. C., Gayer, C. R. M., Raymond, B., Coelho, M. G. P., Marques, E. A., Touqui, L., Albano, R. M., et al. (2005) · Cellular Microbiology · doi:10.1111/j.1462-5822.2005.00635.x · Cited by 90
Pseudomonas aeruginosa exoenzyme S, a bifunctional type-III secreted cytotoxin
Barbieri, J. T. (2000) · International Journal of Medical Microbiology · doi:10.1016/s1438-4221(00)80047-8 · Cited by 89
Pankhaniya, R. R., Tamura, M., Allmond, L. R., Moriyama, K., Ajayi, T., Wiener-Kronish, J. P., & Sawa, T. (2004) · Critical Care Medicine · doi:10.1097/01.ccm.0000145588.79063.07 · Cited by 81
Implications of oxidative stress in the cytotoxicity of Pseudomonas aeruginosa ExoU
Saliba, A. M., Assis, M.-C., Nishi, R., Raymond, B., Marques, E. A., Lopes, U. G., Touqui, L., & Plotkowski, M. C. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.07.011 · Cited by 79
Identification of Superoxide Dismutase as a Cofactor for the Pseudomonas Type III Toxin, ExoU
Sato, H., Feix, J. B., & Frank, D. W. (2006) · Biochemistry · doi:10.1021/bi060788j · Cited by 78
Lee, V. T., Pukatzki, S. U., Satō, H., Kikawada, E., Kazimirova, A. A., Huang, J., Li, X., Arm, J. P., Frank, D. W., & Lory, S. (2006) · Infection and Immunity · doi:10.1128/iai.01184-06 · Cited by 78
Multiple Domains Are Required for the Toxic Activity of Pseudomonas aeruginosa ExoU
Finck‐Barbançon, V., & Frank, D. W. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.14.4330-4344.2001 · Cited by 75
Belyy, A., Raoux-Barbot, D., Saveanu, C., Namane, A., Ogryzko, V., Worpenberg, L., David, V., Henriot, V., Fellous, S., Merrifield, C., et al. (2016) · Nature Communications · doi:10.1038/ncomms13582 · Cited by 72
Rabin, S. D. P., Veesenmeyer, J. L., Bieging, K. T., & Hauser, A. R. (2006) · Infection and Immunity · doi:10.1128/iai.74.5.2552-2561.2006 · Cited by 57
Plotkowski, M. C., Brandão, B. A., Assis, M.-C., Feliciano, L.-F. P., Raymond, B., de Freitas, C. S., Saliba, A. M., Zahm, J., Touqui, L., & Bozza, P. T. (2008) · Microbial Pathogenesis · doi:10.1016/j.micpath.2008.01.008 · Cited by 46
Tyson, G. H., & Hauser, A. R. (2013) · Infection and Immunity · doi:10.1128/iai.00414-13 · Cited by 46
ExoU Activates NF-κB and Increases IL-8/KC Secretion during Pseudomonas aeruginosa Infection
de Lima, C. D. M., Calegari-Silva, T. C., Pereira, R. M. S., Santos, S. A. D. O. L., Lopes, U. G., Plotkowski, M.-C. M., & Saliba, A. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041772 · Cited by 45
Ubiquitin Activates Patatin-Like Phospholipases from Multiple Bacterial Species
Anderson, D. M., Satō, H., Dirck, A. T., Feix, J. B., & Frank, D. W. (2014) · Journal of Bacteriology · doi:10.1128/jb.02402-14 · Cited by 45
Hardy, K. S., Tessmer, M. H., Frank, D. W., & Audia, J. P. (2021) · Toxins · doi:10.3390/toxins13120880 · Cited by 43
Self-citationPseudomonas aeruginosa exoenzymes U and Y induce a transmissible endothelial proteinopathy
Morrow, K. A., Ochoa, C. D., Balczon, R., Zhou, C., Cauthen, L., ALEXEYEV, M. F., Schmalzer, K. M., Frank, D. W., & Stevens, T. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00103.2015 · Cited by 40
Self-citationTyson, G. H., Halavaty, A. S., Kim, H., Geissler, B., Agard, M., Satchell, K. J. F., Cho, W., Anderson, W. F., & Hauser, A. R. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.611251 · Cited by 40
Housley, N. A., Winkler, H. H., & Audia, J. P. (2011) · Journal of Bacteriology · doi:10.1128/jb.00141-11 · Cited by 36
Self-citationActivation of ExoU Phospholipase Activity Requires Specific C-Terminal Regions
Schmalzer, K. M., Benson, M. A., & Frank, D. W. (2010) · Journal of Bacteriology · doi:10.1128/jb.00904-09 · Cited by 34
Audia, J. P., Lindsey, A. S., Housley, N. A., Ochoa, C. R., Zhou, C., Toba, M., Oka, M., Annamdevula, N. S., Fitzgerald, M. S., Frank, D. W., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081792 · Cited by 30
Self-citationPseudomonas aeruginosa ExoU augments neutrophil transepithelial migration
Pazos, M. A., Lanter, B. B., Yonker, L. M., Eaton, A. D., Pirzai, W., Gronert, K., Bonventre, J. V., & Hurley, B. P. (2017) · PLoS Pathogens · doi:10.1371/journal.ppat.1006548 · Cited by 26
Measuring Inflammasome Activation in Response to Bacterial Infection
Brož, P., & Monack, D. M. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-523-1_6 · Cited by 22
Renema, P., Kozhukhar, N., Pastukh, V. V., Spadafora, D., Paudel, S. S., Tambe, D. T., ALEXEYEV, M. F., Frank, D. W., & Stevens, T. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00508.2019 · Cited by 20
Self-citationda Cunha, L. G., Ferreira, M. F., Moraes, J. A., Reis, P. A., Castro-Faria-Neto, H. C., Barja‐Fidalgo, C., Plotkowski, M. C., & Saliba, A. M. (2015) · Medical Microbiology and Immunology · doi:10.1007/s00430-015-0418-x · Cited by 17
Caspase-1 Activation Protects Lung Endothelial Barrier Function during Infection-Induced Stress
Alvarez, D. F., Housley, N. A., Koloteva, A., Zhou, C., O’Donnell, K., & Audia, J. P. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2015-0386oc · Cited by 17
Self-citationRenema, P., Hardy, K. S., Housley, N. A., Dunbar, G. E., Annamdevula, N. S., Britain, A. L., Spadafora, D., Leavesley, S. J., Rich, T. C., Audia, J. P., et al. (2020) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00185.2019 · Cited by 10
Self-citationUbiquitin and ubiquitin‐modified proteins activate the Pseudomonas aeruginosa T3SS cytotoxin, ExoU
Anderson, D. M., Schmalzer, K. M., Satō, H., Casey, M., Terhune, S. S., Haas, A. L., Feix, J. B., & Frank, D. W. (2011) · Molecular Microbiology · doi:10.1111/j.1365-2958.2011.07904.x
Schulert, G. S., Feltman, H., Rabin, S. D. P., Martin, C. G., Battle, S. E., Rello, J., & Hauser, A. R. (2003) · The Journal of Infectious Diseases · doi:10.1086/379372
Type III Secretion of ExoU Is Critical during Early Pseudomonas aeruginosa Pneumonia
Howell, H. A., Logan, L. K., & Hauser, A. R. (2013) · mBio · doi:10.1128/mbio.00032-13
Anderson, D. M., Feix, J. B., Monroe, A. L., Peterson, F. C., Volkman, B. F., Haas, A. L., & Frank, D. W. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.478529
Lins, R. X., de Assis, M. C., de Lima, C. D. M., de Freitas, C. S., Plotkowski, M. C., & Saliba, A. M. (2009) · Microbes and Infection · doi:10.1016/j.micinf.2009.11.005
de Freitas, C. S., Assis, M.-C., Saliba, A. M., Morandi, V., Figueiredo, C. C., Pereira, M. C. D. S., & Plotkowski, M. C. (2012) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/s0074-02762012000600004
Wagener, B. M., Anjum, N., Christiaans, S. C., Banks, M. E., Parker, J. C., Threet, A., Walker, R. R., Isbell, K. D., Moser, S. A., Stevens, T., et al. (2020) · Toxins · doi:10.3390/toxins12060369
Self-citationBouillot, S., Attrée, I., & Huber, P. (2015) · Infection and Immunity · doi:10.1128/iai.00010-15
Eukaryotic localization, activation and ubiquitinylation of a bacterial type III secreted toxin
Stirling, F. R., Cuzick, A., Kelly, S. M., Oxley, D., & Evans, T. J. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00710.x
Veesenmeyer, J. L., Howell, H., Halavaty, A. S., Ahrens, S., Anderson, W. F., & Hauser, A. R. (2010) · Infection and Immunity · doi:10.1128/iai.00223-10
A sensitive fluorescence-based assay for the detection of ExoU-mediated PLA2 activity
Benson, M. A., Schmalzer, K. M., & Frank, D. W. (2009) · Clinica Chimica Acta · doi:10.1016/j.cca.2009.10.025
Bagayoko, S., Icaza, S. L., Pinilla, M., Hessel, A., Santoni, K., Bordignon, P.-J., Moreau, F., Eren, E., Boyancé, A., Naser, E., et al. (2021) · doi:10.1101/2021.02.17.431580
Cited by
Qin, S., Xiao, W., Zhou, C., Pu, Q., Deng, X., Lan, L., Liang, H., Song, X., & Wu, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01056-1 · Cited by 1,703
Metadata
- Authors
- Hardy, K. S., Tuckey, A. N., Renema, P., Patel, M., Al-Mehdi, A.-B., Spadafora, D., Schlumpf, C. A., Barrington, R. A., Alexeyev, M. F., Stevens, T., Pittet, J.-F., Wagener, B. M., Simmons, J. D., Alvarez, D. F., & Audia, J. P.
- Affiliations
- Department of Microbiology and Immunology, College of Medicine, University of South Alabama, Mobile, AL 36688, USA
- Center for Lung Biology, College of Medicine, University of South Alabama, Mobile, AL 36688, USA
- Flow Cytometry Core Lab, College of Medicine, University of South Alabama, Mobile, AL 36688, USA
- Department of Anesthesiology and Perioperative Medicine, Birmingham School of Medicine, University of Alabama, Birmingham, AL 35294, USA
- Venue
- Toxins
- Publisher
- MDPI AG
- Published
- 2022-02-18
- Volume
- 14
- Issue
- 2
- Pages
- 152
- ISSN
- 2072-6651
- Cited by
- 21
- References
- 75
- Language
- en
- Funders
- National Heart Lung and Blood Institute (HL118334, HL118334-S1)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.